7.4 PLANNING AND EVALUATION Program planning and evaluation activities are essential to the continued success of the Arizona Cancer Center (AZCC), and is critical in achieving our highest priorities. To that end, the leadership of the Arizona Cancer Center strives to maintain a culture and an environment which promotes the discovery, translation, and delivery of services which is necessary in order to meet our mission. In that endeavor, the continuous planning and evaluation of our activities is necessary. Since we are a matrix center in a highly complex environment, we employ many different mechanisms for receiving advice and contributions from our members to ensure maximum input and communication. The AZCC utilizes six formal mechanisms and one informal mechanism for program planning and evaluation. The formal methods are as follows: a. External Scientific Advisory Board; b. Retreats; c. Individual program meetings; d. Arizona Cancer Center Director's Meeting; e. Arizona Cancer Center Executive Committee (campus-wide advisory board); f. Cancer Center Board (state-wide lay advisory board); The informal method is the intake of day-to-day suggestions by individual AZCC members based on their requirements for conducting basic, translational, or clinical science. Each of these mechanisms and the help they have provided is detailed in the narrative section. An annual budget of $85,000 is requested for the continuation of this effort.

Public Health Relevance

Planning and evaluation activities are critical to the mission of the Center. These activities allow for growth of scientific programs, increased collaborations, planning for new faculty recruits, implementation of new standards, and identification of required resources for new advances in technology and equipment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023074-34
Application #
8377784
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
34
Fiscal Year
2012
Total Cost
$109,532
Indirect Cost
$37,234
Name
University of Arizona
Department
Type
DUNS #
806345617
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Agasid, Mark T; Wang, Xuemin; Huang, Yiding et al. (2018) Expression, purification, and electrophysiological characterization of a recombinant, fluorescent Kir6.2 in mammalian cells. Protein Expr Purif 146:61-68
Wales, Jessica A; Chen, Cheng-Yu; Breci, Linda et al. (2018) Discovery of stimulator binding to a conserved pocket in the heme domain of soluble guanylyl cyclase. J Biol Chem 293:1850-1864
Hsu, Chiu-Hsieh; Yu, Mandi (2018) Cox regression analysis with missing covariates via nonparametric multiple imputation. Stat Methods Med Res :962280218772592
Lindeman, Leila R; Randtke, Edward A; High, Rachel A et al. (2018) A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo pH. Magn Reson Med 79:2766-2772
Remeniuk, Bethany; King, Tamara; Sukhtankar, Devki et al. (2018) Disease modifying actions of interleukin-6 blockade in a rat model of bone cancer pain. Pain 159:684-698
Bell, Melanie L (2018) New guidance to improve sample size calculations for trials: eliciting the target difference. Trials 19:605
Blohm-Mangone, Karen; Burkett, Nichole B; Tahsin, Shekha et al. (2018) Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 Mice. Cancer Prev Res (Phila) 11:265-278
Tao, Shasha; Rojo de la Vega, Montserrat; Chapman, Eli et al. (2018) The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer. Mol Carcinog 57:182-192
Goldenberg, Joshua M; Pagel, Mark D; Cárdenas-Rodríguez, Julio (2018) Characterization of D-maltose as a T2 -exchange contrast agent for dynamic contrast-enhanced MRI. Magn Reson Med 80:1158-1164
Bell, Melanie L; Whitehead, Amy L; Julious, Steven A (2018) Guidance for using pilot studies to inform the design of intervention trials with continuous outcomes. Clin Epidemiol 10:153-157

Showing the most recent 10 out of 1336 publications